Redesigning obesity trials for a chronic disease era
For much of its history, obesity research has occupied an awkward space within clinical development. Too medical to dismiss outright, yet, too entangled with lifestyle narratives to command the same seriousness as closely linked conditions like cardiovascular disease or diabetes, it has often been studied through a narrow lens – short trials, blunt endpoints, and a lingering assumption that weight loss alone was the outcome that mattered.
Industry Events & Conferences
ASD Conference 2026
Optimism, Courage, and Pragmatism – Human Pharmacology 2030 Thursday, 24th February 2026 Pre-Meeting Workshop | ...
Innovation for Health 2026
Innovation for Health is the leading conference in the Netherlands, bringing together key stakeholders from across the ...
Open Day at CRS Kiel What Works Tomorrow – Liver Cirrhosis Between Research, Pipeline and Practice
Open Day at CRS Kiel What Works Tomorrow – Liver Cirrhosis Between Research, Pipeline and Practice We are delighted to ...
Networking Evening at CRS Mannheim Cardiometabolic Diseases: The Update
Networking Evening at CRS Mannheim Cardiometabolic Diseases: The Update We are pleased to invite physicians from ...
16th Annual Outsourcing in Clinical Trials Europe 2026
Advance Your Clinical Trials with Insight, Innovation and the Right Partners hVIVO will be attending OCT Europe, with ...
SaxoCell Conference on Cell and Gene Therapy
Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...
11th German Pharm-Tox Summit 2026
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...
World Vaccine Congress Europe
Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World Vaccine Congress ...
BIO-Europe 2026
Connect with the Right Partners to Accelerate Biopharma Growth hVIVO will be attending BIO-Europe, the leading ...
Dutch Life Sciences Conference 2026
Connect with Europe’s Leading Life Sciences Ecosystem hVIVO will be attending the Dutch Life Sciences Conference, a key ...
Hands On Workshops
IND Enabling Workshop
What You'll Learn A proven framework to reduce development risk and fast‑track your asset to clinic Strategic ...
IND Enabling Workshop
A case-based, interactive workshop designed to equip participants with the tools needed to navigate the path to ...
Target Product Profile (TPP) Workshop
An interactive session where we work hands-on with participating companies to structure their drug concept in a ...
On-Demand Education
.jpg)
Accelerate your RSV Programme with our RSV Human Challenge Model
About RSV & why developing RSV antivirals and vaccines are critical Respiratory Syncytial Virus (RSV) is a common, ...
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Technical Due Diligence in Drug Development: What Startup Founders Need to Know to Succeed
Join industry experts for an interactive discussion on mastering technical due diligence. Due diligence is a critical ...
Upcoming Live Webinars
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Smarter Molecular Strategies for Infectious Disease Trials: Turning Complex Data into Clinical Advantage
Turning complex molecular data into clinical advantage As infectious disease programs face increasing pressure to ...
News & Resources
From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
Controlled Human Infection Model's (CHIM) in your backpack: how Human Challenge Trials support regulatory approval of travel vaccines
Unravelling the hMPV Surge: From Media Attention to Vaccine Development
Why are Biotech’s & Pharma Using Human Challenge Studies for Drug Development?
Tripledemic Takedown: How Human Challenge Trials are Ideal to Expedite Multivalent Vaccine Development
Empowering Next‑Gen Infectious Disease & Vaccine Development
Human Challenge Studies: Their Conduct and Safety Aspects
Human Challenge Trials as a tool in raising funding
UK Life Sciences Sector Plan 2025: What it Means for the Future of Clinical Research
The UK Regulatory Competitiveness in an ever changing world